Enterococcus: Difference between revisions

From IDWiki
Enterococcus
Content deleted Content added
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 37: Line 37:


* [[Vancomycin]] is usually reliable (except for [[Enterococcus gallinarum]] and [[Enterococcus casseliflavus]])
* [[Vancomycin]] is usually reliable (except for [[Enterococcus gallinarum]] and [[Enterococcus casseliflavus]])
* [[Ampicillin]] is preferred for susceptible strains
* [[Ampicillin]] or [[amoxicillin]] is preferred for susceptible strains
** [[Piperacillin]] is effective, as well, but not [[cloxacillin]]
* Inherent resistance to [[cephalosporins]]
* Inherent resistance to [[cephalosporins]]
* Resistant to [[ertapenem]], but ampicillin-susceptible strains are often susceptible to [[imipenem]] and (less reliably) to [[meropenem]]
* Resistant to [[ertapenem]], but ampicillin-susceptible strains are often susceptible to [[imipenem]] and (less reliably) to [[meropenem]][[CiteRef::fraenkel2006in]][[CiteRef::10.1093/jac/39.2.149]]


===VRE===
===VRE===

Latest revision as of 14:45, 14 November 2025

Background

Microbiology

  • Genus of facultative anaerobic, non-spore-forming, alpha- or gamma-hemolytic, catalase negative, Gram-positive cocci
  • Grows on bile esculin agar
  • PYR positive
  • Most are Lancefield group D
  • Commensal gut flora
  • Increasing antibiotic resistance

Species

Vancomycin Resistance

  • Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
  • VanA: most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
  • VanB: more common in E. faecium in Australia
  • VanC: chromosomal resistance on E. gallinarum and E. casseliflavus

Management

VRE

References

  1. ^  Carl-Johan Fraenkel, Måns Ullberg, Sverker Bernander, Evalena Ericson, Peter Larsson, Johan Rydberg, Eva Törnqvist, Åsa Melhus. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals. Scandinavian Journal of Infectious Diseases. 2006;38(10):853-859. doi:10.1080/00365540600684371.
  2. ^  James H. Jorgensen, Sharon A. Crawford, Cynthia C. Kelly, Jan E. Patterson. In VitroActivity of Daptomycin against Vancomycin-Resistant Enterococci ofVarious Van Types and Comparison of Susceptibility TestingMethods. Antimicrobial Agents and Chemotherapy. 2003;47(12):3760-3763. doi:10.1128/aac.47.12.3760-3763.2003.